Phase II study of cetuximab in combination with FOLFIRI in patients with untreated advanced gastric or gastroesophageal junction adenocarcinoma (FOLCETUX study)

C. Pinto, F. Di Fabio, S. Siena, S. Cascinu, F. L. Rojas Llimpe, C. Ceccarelli, V. Mutri, L. Giannetta, S. Giaquinta, C. Funaioli, R. Berardi, C. Longobardi, E. Piana, A. A. Martoni

Research output: Contribution to journalArticlepeer-review

Fingerprint Dive into the research topics of 'Phase II study of cetuximab in combination with FOLFIRI in patients with untreated advanced gastric or gastroesophageal junction adenocarcinoma (FOLCETUX study)'. Together they form a unique fingerprint.

Medicine & Life Sciences